Literature DB >> 14599605

Major lower extremity amputations at a Veterans Affairs hospital.

Carlos P Cruz1, John F Eidt, Christy Capps, Leah Kirtley, Mohammed M Moursi.   

Abstract

BACKGROUND: This study was made to evaluate the experience at a Department of Veterans Affairs (VA) hospital with consecutive major lower extremity amputations over a period of 7 years.
METHODS: The records of 229 patients (221 male and 8 female) who underwent 296 consecutive major lower extremity amputations (119 above-knee amputations [AKA] and 177 below-knee amputations [BKA]) over a period of 86 months (September 1994 to October 2001) were retrospectively analyzed. All amputations were performed by members of the vascular surgery department.
RESULTS: Forty of the 229 patients (17%) eventually required a contralateral amputation, 27 patients (12%) had BKAs that eventually necessitated conversion to AKA, and 44 amputations (15%) required an initial guillotine amputation. The 30-day mortalities for BKA, AKA, and BKA to AKA operations were 12%, 17%, and 7%, respectively. Eighty-eight of the amputations (30%) developed wound complications, and required 137 revisions. Seventy-seven of the amputations (26%) had undergone prior revascularization, of which 31 (48%) had an early failed bypass. The average preoperative ankle/brachial index (ABI) was 0.57. Of the patients undergoing amputation, 97 (42%) complained of rest pain, 91 (40%) complained of claudication, and 158 (69%) had tissue loss or gangrene at the time of their operation. One hundred and forty-six patients (64%) were diabetic. Twenty-two patients (9%) were dialysis dependent and 81 patients (35%) admitted to smoking. Of the known causes of death, 21 resulted from myocardial infarction, 22 from congestive heart failure, 14 from respiratory failure, 13 from disseminated cancer, 10 from sepsis, 7 from stroke, and 6 from renal failure. Preoperative functional status determinations revealed that of 272 patients with enough information to assess functional status, 43 were totally dependent, 97 were partially independent, and 132 were independent. Of the 229 patients, 168 (73%) were ambulatory prior to their amputation, and at the completion of this review only 53 patients (23%) were ambulatory.
CONCLUSIONS: Most patients undergoing major lower extremity amputations have many comorbidities; hence morbidity and mortality rates are high, with the most common causes of death being cardiac and respiratory in nature. These data suggest that major lower extremity amputations highlight a very high-risk population with only 39% survival at 7 years, as well as a costly subset secondary to prolonged hospitalization times (average 15 days, range 3 to 105), in addition to the extraordinary cost associated with diminished functional status.

Entities:  

Mesh:

Year:  2003        PMID: 14599605     DOI: 10.1016/j.amjsurg.2003.07.027

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  27 in total

1.  Prognostic differences for functional recovery after major lower limb amputation: effects of the timing and type of inpatient rehabilitation services in the Veterans Health Administration.

Authors:  Margaret G Stineman; Pui L Kwong; Dawei Xie; Jibby E Kurichi; Diane Cowper Ripley; David M Brooks; Douglas E Bidelspach; Barbara E Bates
Journal:  PM R       Date:  2010-04       Impact factor: 2.298

2.  Biomarkers in post-reperfusion syndrome after acute lower limb ischaemia.

Authors:  Stefano de Franciscis; Giovanni De Caridi; Mafalda Massara; Francesco Spinelli; Luca Gallelli; Gianluca Buffone; Francesco G Caliò; Lucia Butrico; Raffaele Grande; Raffaele Serra
Journal:  Int Wound J       Date:  2014-12-03       Impact factor: 3.315

3.  Inflammatory "adiposopathy" in major amputation patients.

Authors:  Christine R Mauro; Binh T Nguyen; Peng Yu; Ming Tao; Ian Gao; Michael A Seidman; Louis L Nguyen; C Keith Ozaki
Journal:  Ann Vasc Surg       Date:  2013-04       Impact factor: 1.466

4.  Preoperative Predictors of 30-Day Mortality and Prolonged Length of Stay after Above-Knee Amputation.

Authors:  Eric S Wise; William G McMaster; Kelly Williamson; Justine E Wergin; Kyle M Hocking; Colleen M Brophy
Journal:  Ann Vasc Surg       Date:  2015-11-23       Impact factor: 1.466

5.  Factors associated with home discharge after rehabilitation among male veterans with lower extremity amputation.

Authors:  Jibby E Kurichi; Diane Cowper Ripley; Dawei Xie; Pui L Kwong; Barbara E Bates; Margaret G Stineman
Journal:  PM R       Date:  2012-11-14       Impact factor: 2.298

6.  Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008.

Authors:  W Schuyler Jones; Manesh R Patel; David Dai; Sumeet Subherwal; Judith Stafford; Sarah Calhoun; Eric D Peterson
Journal:  J Am Coll Cardiol       Date:  2012-10-24       Impact factor: 24.094

7.  Fate of the contralateral limb after lower extremity amputation.

Authors:  Julia D Glaser; Rodney P Bensley; Rob Hurks; Suzanne Dahlberg; Allen D Hamdan; Mark C Wyers; Elliot L Chaikof; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2013-08-03       Impact factor: 4.268

8.  Functional outcome after redo below-knee amputation.

Authors:  Chad N Stasik; Scott A Berceli; Peter R Nelson; W Anthony Lee; C Keith Ozaki
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

9.  A Canadian population-based description of the indications for lower-extremity amputations and outcomes.

Authors:  Ahmed Kayssi; Charles de Mestral; Thomas L Forbes; Graham Roche-Nagle
Journal:  Can J Surg       Date:  2016-04       Impact factor: 2.089

10.  Predictors of early mortality and readmissions among dialysis patients undergoing lower extremity amputation.

Authors:  LaTonya J Hickson; Andrew D Rule; Bjorg Thorsteinsdottir; Raymond C Shields; Ivan E Porter; Mark D Fleming; Daniel S Ubl; Cynthia S Crowson; Kristine T Hanson; Bassem T Elhassan; Rajnish Mehrotra; Shipra Arya; Robert C Albright; Amy W Williams; Elizabeth B Habermann
Journal:  J Vasc Surg       Date:  2018-06-28       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.